“…However, it is noteworthy that myalgia is a relatively common adverse reaction to bumetanide as it is to frusemide (Cuthbert, 1975) and that muscle stiffness also occurs frequently after bumetanide (Berg, Tromsdal & Wider0e, 1975). Therefore, apart from the acute manifestation of myotonia, the myopathies and neuropathies resulting from chronic exposure to myotonic agents (RUdiger et al, 1972;Prescott et al, 1979;Wallis, Poznak, Plum, 1970) require consideration. Indeed, the frequent association of dystrophy with myotonia, also in the hereditary myotonias, begs the question of whether there is any casual relationship (Bryant, 1977).…”